CDKs - the chart-topping hit on the breast cancer playlist

Prof Carol-Ann Benn explains why CDK inhibitors are topping the breast cancer playlist for luminal breast cancers. This podcast is brought to you by Boston Scientific. Statements of fact and opinions expressed in this episode belong to the contributor and do not necessarily reflect the opinion or position of Boston Scientific. Prof Carol-Ann Benn heads up an internationally accredited, multi-disciplinary breast cancer centre at Netcare Milpark Hospital. She lectures at Wits University and, in 2002, established the Breast Health Foundation. Facebook · Twitter · Instagram · LinkedIn